日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

DNA和RNA谱分析的一致性分析:MD安德森癌症中心IMPACT2精准肿瘤学研究

Schmidt, Stephanie T; Baysal, Mehmet A; Fu, Siqing; Hong, David S; Piha-Paul, Sarina A; Naing, Aung; Rodon Ahnert, Jordi; Yap, Timothy A; Dumbrava, Ecaterina Elena; Beck, Jennifer; Meric-Bernstam, Funda; Tsimberidou, Apostolia Maria

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial

认知障碍与绝经前和绝经后妇女的化学内分泌治疗与内分泌治疗:RxPONDER随机临床试验的二次分析

Kang, Irene M; Forschmiedt, Jamie K; Loch, Michelle M; Lew, Danika L; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Rastogi, Priya; Schott, Anne F; Baehner, Rick; Sharma, Priyanka; Tripathy, Debasish; Pusztai, Lajos; Hortobagyi, Gabriel N; Kalinsky, Kevin; Henry, N Lynn

CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction

CDK2抑制剂BLU-222通过诱导p21/p27与CDK4/6抑制剂协同作用,治疗耐药性乳腺癌。

Luo, Linjie; Wang, Yan; Bui, Tuyen; Jiang, Xiaoting; Chen, Mei-Kuang; Rao, Xiayu; Mohammadhosseinpour, Sepideh; Li, Mi; Kim, Serena; Kim, Rachel Y; Kamaliasl, Saba; Ulizio, Carmen W; Tsavachidis, Spyros; Navarro-Yepes, Juliana; Kettner, Nicole M; Wingate, Hannah; Meric-Bernstam, Funda; Hunt, Kelly K; Wang, Jing; Faia, Kerrie; Keyomarsi, Khandan

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

针对HER2靶向治疗癌症亚型的进展:一种泛肿瘤方法

Adesoye, Taiwo; Dumbrava, Ecaterina E; Raghav, Kanwal P S; Sahin, Aysegul A; Chen, Hui; Lee, Sunyoung S; Javle, Milind M; Pant, Shubham; Alhalabi, Omar; Le, Xiuning; Valero, Vicente; Pohlmann, Paula R; Meric-Bernstam, Funda

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion

贝伐珠单抗联合替西罗莫司治疗晚期恶性肿瘤的I期研究:安全性、疗效及卵巢癌扩展研究

Piha-Paul, Sarina A; Tseng, Chieh; Thompson, Emily; Stafford, R Jason; Le, Hung; Kang, Lei; Fu, Siqing; Tsimberidou, Apostolia; Blumenschein, George; Ahnert, Jordi Rodon; Slopis, John M; Hong, David; Naing, Aung; Meric-Bernstam, Funda; Ng, Chaan S; Westin, Shannon; Sood, Anil K

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

Tumor microenvironment changes after treatment with avelumab and immune-stimulating agent combinations in patients with advanced solid tumors

阿维鲁单抗联合免疫刺激剂治疗晚期实体瘤患者后肿瘤微环境的变化

Lermi, Nejla Ozirmak; Gouda, Mohamed A; Ahmed, Jibran; Jiang, Xianli; Lee, Younghee; Mohanty, Vakul; Derbala, Mohamed; Stephen, Bettzy; Jhingran, Anuja; Mohammad, Mohammad Moustafa; Joo, Donghyun; Francisco-Cruz, Alejandro; Chen, Honglei; Calderon, Luis Acosta; Laberiano, Caddie; Arrechedera, Claudio; Pandurengan, Renganayaki; Gurses, Serdar; Yang, Yali; Solis Soto, Luisa M; Ahnert, Jordi Rodon; Chen, Ken; Meric-Bernstam, Funda; Koay, Eugene Jon; Javle, Milind; Haymaker, Cara; Naing, Aung

Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial

Zanidatamab 单药治疗或联合化疗治疗 HER2 表达阳性的胃食管腺癌:一项 1 期试验

Meric-Bernstam, Funda; Rha, Sun Young; Hamilton, Erika; Kang, Yoon-Koo; Hanna, Diana L; Iqbal, Syma; Lee, Keun-Wook; Lee, Jeeyun; Beeram, Muralidhar; Oh, Do-Youn; Chaves, Jorge; Goodwin, Rachel A; Ajani, Jaffer A; Yang, Lin; Oza, Rajen; Elimova, Elena

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models

在乳腺癌模型中,FGFR3诱导的Y158 PARP1磷酸化通过BRG1/MRE11介导的DNA修复促进PARP抑制剂耐药性

Chen, Mei-Kuang; Yamaguchi, Hirohito; Gao, Yuan; Xia, Weiya; Chang, Jeffrey T; Hsiao, Yu-Chun; Shegute, Tewodros W; Lin, Zong-Shin; Wu, Chen-Shiou; Wang, Yu-Han; Litton, Jennifer K; Ding, Qingqing; Wei, Yongkun; Chu, Yu-Yi; Meric-Bernstam, Funda; Piwnica-Worms, Helen; Arun, Banu; Rodon Ahnert, Jordi; Liu, Jinsong; Yao, Jun; Chang, Wei-Chao; Wang, Hung-Ling; Tapia, Coya; Albarracin, Constance T; Keyomarsi, Khandan; Wang, Shao-Chun; Wang, Ying-Nai; Hortobagyi, Gabriel N; Lin, Chunru; Yang, Liuqing; Yu, Dihua; Hung, Mien-Chie